🔎 Trials Near Me

Hjem › Migræne › Illinois

Migræne kliniske forsøg i Illinois

6 studier for Migræne søger deltagere på steder i Illinois.

Byer i Illinois

Officiel studietekst (engelsk)

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

  • Chicago Headache Center & Research Institute, Chicago
  • AMR-Baber Research Inc, Naperville
RekruttererFase 3
Alder 6 til 17 · Alle køn · Opdateret 24. sep. 2026 · NCT04743141

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

  • Chicago Headache Center & Research Institute, Chicago
  • AMR-Baber Research Inc, Naperville
RekruttererFase 3
Alder 6 til 17 · Alle køn · Opdateret 24. sep. 2026 · NCT04649242

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

  • Chicago Headache Center & Research Institute /ID# 248625, Chicago
  • Ascension Saint Alexius /ID# 275261, Hoffman Estates
RekruttererFase 3
Alder 6 til 17 · Alle køn · Opdateret 14. sep. 2026 · NCT05125302

A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

  • Cedar Crosse Research Center, Chicago
  • Chicago Headache Center & Research Institute, Chicago
  • Healthcare Research Network II, LLC, Flossmoor
  • og 1 flere
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 20. aug. 2026 · NCT07645924

Study to Assess the Real-World Effectiveness of Ubrogepant in Adult Participants When Treating During the Prodrome Phase of Migraine Attacks

  • Chicago Headache Center & Research Inst /ID# 272345, Naperville
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 10. feb. 2026 · NCT07310290

Effectiveness of Magnesium in Addition to Prochlorperazine for the Treatment of Migraines

  • Advocate Christ Medical Center Emergency Department, Oak Lawn
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 22. jan. 2026 · NCT06904287

Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.